Skip to main content

Life Sciences

Why The Shared Investigator Platform (SIP) Was Created

medical exam

This is the second post in a series on the TransCelerate Shared Investigator Platform (SIP). For background information on TransCelerate, see the initial post in the series.

Very few doctors serve as clinical investigators (approximately 3%), which means many investigators work with multiple sponsor organizations. Each sponsor organization has its own site-facing IT systems and business processes, meaning that these investigators need to remember which URLs, login credentials, and processes to use for which sponsor/study – on top of their patient interactions and other administrative duties.

Adding another level of complexity, any one investigator can easily be working on multiple studies for a single sponsor, and each of those studies might use a different combination of site-facing systems and processes, depending on how long they have been running and whether they are being managed by the sponsor or a contract research organization (CRO).

The Sites Subcommittee of TransCelerate decided to address the burden of clinical trial administration placed on site investigators by creating the SIP.

Check back for the next post in this series, which will describe why the SIP is such an attractive solution. In the meantime, check out this brief video that describes a project we completed for one of the TransCelerate member companies, and fill out the form below to download our related guide, Perspectives on the TransCelerate Shared Investigator Platform.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Marin Richeson

Marin joined the life sciences industry in 2001. Over the course of her tenure, she has held roles in clinical finance, IT, quality assurance, and validation. The diversity of her experience provides her with a unique perspective on the interconnectedness of this complex, multi-faceted industry. Marin Richeson is a lead business consultant in Perficient's life sciences practice.

More from this Author

Follow Us